Recent Updates — BON

Bon Natural Life Limited reported a net loss attributable to shareholders of $9.2 million for the six months ended March 31, 2026, compared to a net income of $169,227 in the prior year period. Revenue increased slightly by 1.9% to $8.1 million, driven by significant volume growth in health supplements and bioactive food ingredients, which was partially offset by a 40.2% decline in fragrance compound sales. The company recorded substantial non-cash charges, including a $5.7 million provision for credit losses against accounts and other receivables and a $1.9 million impairment on advances to suppliers. Operating expenses surged due to increased selling costs and amortization of share-based compensation paid to third-party advisors. Bon Natural Life Limited operates in the bio-ingredient industry, manufacturing functional active ingredients extracted from natural herbs for use in food, personal care, and pharmaceutical products.